| # | Drug | Count |
|---|---|---|
| 0 | BENRALIZUMAB | 2 |
| 1 | FULVESTRANT | 2 |
| 2 | OFATUMUMAB | 2 |
| 3 | RIBOCICLIB | 2 |
| 4 | ACETAMINOPHEN | 1 |
| 5 | ACETAMINOPHEN 500MG | 1 |
| 6 | ACETAMINOPHEN TABLET EXTENDED RELEASE | 1 |
| 7 | DOCUSATE SODIUM | 1 |
| 8 | DUPILUMAB | 1 |
| 9 | FENTANYL | 1 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | MARALIXIBAT CHLORIDE | 1 | 0.0010 |
| 1 | BENRALIZUMAB | 2 | 0.0001 |
| 2 | RIBOCICLIB | 2 | 0.0001 |
| 3 | FULVESTRANT | 2 | 0.0001 |
| 4 | OFATUMUMAB | 2 | 0.0001 |
| 5 | HUMAN IMMUNOGLOBULIN G | 1 | 0.0000 |
| 6 | TAPENTADOL HYDROCHLORIDE | 1 | 0.0000 |
| 7 | IXEKIZUMAB | 1 | 0.0000 |
| 8 | DOCUSATE SODIUM | 1 | 0.0000 |
| 9 | ORAL SEMAGLUTIDE | 1 | 0.0000 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Interleukin-5 Receptor alpha-directed Cytolytic Antibody [EPC] | 2 | 0.0001 |
| 1 | Estrogen Receptor Antagonist [EPC] | 2 | 0.0000 |
| 2 | Human Immunoglobulin G [EPC] | 1 | 0.0000 |
| 3 | Interleukin-17A Antagonist [EPC] | 1 | 0.0000 |
| 4 | CD20-directed Cytolytic Antibody [EPC] | 2 | 0.0000 |
| 5 | GLP-1 Receptor Agonist [EPC] | 2 | 0.0000 |
| 6 | Opioid Agonist [EPC] | 1 | 0.0000 |
| 7 | Interleukin-4 Receptor alpha Antagonist [EPC] | 1 | 0.0000 |
| 8 | Nonsteroidal Anti-inflammatory Drug [EPC] | 1 | 0.0000 |